Navigation Links
Cheaper DNA Sequencing Coming Closer

By Denise Mann
HealthDay Reporter

WEDNESDAY, July 20 (HealthDay News) -- The race to develop the $1,000 genome test may be heating up. New technology promises to cut costs while speeding the amount of time it takes to decipher all of your genes and potentially provide a personalized report of health risks and possible therapies, a new report says.

The human genome was first mapped in 2001 and cost roughly $1 billion to do. Since then, researchers have been striving to develop less expensive DNA sequencing technologies.

One of those less expensive technologies, developed by Ion Torrent Systems Inc. in San Francisco, uses a semiconductor chip to sense DNA or genetic material instead of light. This eliminates the need for some of the more expensive equipment typically required for such sequencing, and it also works faster, said Dr. Maneesh Jain, vice president of marketing and business development at Ion Torrent.

Researchers were able to scan three bacterial strains and one human genome using the new technology, Jain said.

The new DNA scan uses the same semi-conductor chip technology as digital cameras, and in a way, the evolution of this DNA scanning technology is similar to that of the digital camera, he said.

"When it [digital photography] first started out, the resolution was not good and the pictures were not as good as on film. But the technology improved, which made it more accessible and now more people can enjoy photography and become better photographers," he said.

A report on the new technology is published July 21 in the journal Nature.

As to when the coveted $1,000 gene scan will be available, Jain said that "we are approaching that goal very closely."

Less expensive DNA scanning technology holds significant potential, Jain said. For example, rapidly decoding a bacterial strain could help put the brakes on an outbreak, he said, adding, "We could identify the strain super fast and get the fingerprint and trace it back to its routes."

Other uses of DNA scans include better matching treatments to diseases, Jain said. So-called personalized medicine seeks to avoid trial-and-error by using genetic data found during a scan to better pair treatments with diseases.

These scans can also provide a snapshot of what may be to come with an individual's health. But knowing you may develop a disease isn't always helpful if there's nothing you can do to prevent it.

Jain noted that "if you are genetically predisposed to a disease like diabetes, you can change your lifestyle."

But some medical experts, including Dr. Peter Gregersen, director of the Robert S. Boas Center for Genomics and Human Genetics at the Feinstein Institute for Medical Research in Manhasset, N.Y., are taking a more cautious approach when evaluating the new technology

"Most of what genetics tell us is that there are a lot of fairly common variants that have a modest degree of risk for diseases," Gregersen said. "This is important from a scientific point of view, but the data itself is not actionable.

"The risk of disease associated with high blood pressure, smoking and high cholesterol is far greater than most of the genetic risks coming out of whole genome scanning," Gregersen added. For example, if your genome scan identified a mutation that put you at risk for macular degeneration, a leading cause of blindness, "you may see an ophthalmologist, and there are forms that are treatable, but knowing your genetics won't impact this much," he said.

"Getting it is one thing, but adequately interpreting the information it provides is another big part of this," Gregersen said. "It's a fun thing to do, and there are ways to do it now in which you can contribute to basic science, such as by taking part in a larger registry." But, he added, "In isolation, this information is not helpful yet."

More information

For more on the human genome project, visit the U.S. National Center for Biotechnology Information.

SOURCES: Maneesh Jain, M.D., vice president of marketing and business development, Ion Torrent Systems Inc., San Francisco; Peter Gregersen, M.D., director, the Robert S. Boas Center for Genomics and Human Genetics at the Feinstein Institute for Medical Research, Manhasset, N.Y.; July 21, 2011, Nature

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Cheaper, Older Treatment for Vasculitis Beats Out New Drug
2. Many HIV-Infected Kids Could Use Cheaper Treatment Safely
3. Mathematical models for breast cancer detection with microwave tomography are cheaper and less risky
4. Simpler and cheaper antibiotic prophylaxis with insertion of nutrition catheter in the stomach
5. Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting
6. Gene Sequencing Helps Twins With Rare Disorder
7. Improving DNA sequencing: Sponge-like biosensor crams enormous power into tiny space
8. mygenomatix: A secure cloud-like model for next-gen sequencing data analysis
9. Oxford Nanopore announces licence agreement with Harvard University for graphene DNA sequencing
10. Genome sequencing used to assess a novel form of Clostridium botulinum
11. Whole genome sequencing used to help inform cancer therapy
Post Your Comments:
(Date:11/27/2015)... Francisco, California (PRWEB) , ... November 27, 2015 , ... ... Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of Joplin's ... at the Canterbury House at the University of Michigan in Ann Arbor. The According ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... substance abuse located in central Michigan, have come together on Thanksgiving Day to ... produced video, available for viewing on the Serenity Point YouTube channel, patients displayed ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... , ... The Catalent Applied Drug Delivery Institute today announced ... form selection in early phase drug development. The first of these is to ... the UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating their record ... performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment for the ... to rebuild lives and it’s an honor to have served all of these women.” ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Un nuevo enfoque combina la inmunoterapia con la terapia ... Clinical Cancer Research . --> ...
(Date:11/26/2015)... , November 26, 2015 --> ... to use SyMRI to find optimal contrast weighting of MRI ... metastases, and has signed a research agreement with SyntheticMR in ... hospital. Using SyMRI, it is possible to generate multiple contrast ... after the patient has left, thus making it possible to ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology: